𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Docetaxel and Gemcitabine administered on days 1 and 8 for metastatic non-small cell lung carcinoma (NSCLC): a phase II multicenter trial

✍ Scribed by Hirsh, Vera; Whittom, R.; Desjardins, P.; Laberge, F.; Latreille, J.; Samson, B.; Langleben, A.


Book ID
119318925
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
93 KB
Volume
46
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Weekly paclitaxel and gemcitabine chemot
✍ Vera Hirsh; Renaud Whittom; Linda Ofiara; Pierre Desjardins; Joseph Ayoub; Danie πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The current dose‐optimizing Phase II study evaluated the effect of weekly paclitaxel and gemcitabine on the response rate and survival of patients with non‐small cell lung carcinoma (NSCLC) using dose modifications that permitted optimal treatment intensity. ## METHODS